María del Pilar
Herrera Puente
Profesor/a Asociado/a en CC. de la Salud
Karolinska University Hospital
Estocolmo, SueciaPublications in collaboration with researchers from Karolinska University Hospital (1)
2022
-
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment
Transplantation and Cellular Therapy, Vol. 28, Núm. 5, pp. 258.e1-258.e8